serine and irofulven

serine has been researched along with irofulven in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burks, J; Cunningham, C; Mikell, C; Reed, E; Van Laar, ES; Wang, J; Wang, W; Wang, Y; Waters, SJ; Wiltshire, T	1

Other Studies

1 other study(ies) available for serine and irofulven

Article	Year
ATM-dependent CHK2 activation induced by anticancer agent, irofulven. The Journal of biological chemistry, 2004, Sep-17, Volume: 279, Issue:38 Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Chromosomal Proteins, Non-Histone; DNA-Binding Proteins; Female; Humans; Nuclear Proteins; Ovarian Neoplasms; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; S Phase; Serine; Sesquiterpenes; Signal Transduction; Tumor Suppressor Protein p53; Tumor Suppressor Proteins	2004

Article

Year

ATM-dependent CHK2 activation induced by anticancer agent, irofulven.

The Journal of biological chemistry, 2004, Sep-17, Volume: 279, Issue:38

Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Chromosomal Proteins, Non-Histone; DNA-Binding Proteins; Female; Humans; Nuclear Proteins; Ovarian Neoplasms; Phosphorylation; Protein Kinases; Protein Serine-Threonine Kinases; S Phase; Serine; Sesquiterpenes; Signal Transduction; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2004